High-grade Glioma
📧 Sign up to get email alerts when something new happens for High-grade Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma [Phase 1]
Phase 1 study evaluating the combination of radiation therapy, arsenic trioxide, and temozolomide in newly diagnosed high-grade glioma has c…
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma [Phase 2]
A Phase II study evaluates Gliadel wafers with temozolomide and radiation, followed by dose-dense temozolomide plus bevacizumab, for newly d…
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma [Phase 2]
A Phase II clinical trial is evaluating Gliadel implants with concurrent temozolomide and radiation, followed by dose-dense temozolomide, fo…
-
CLINICAL_TRIALS trial_result · 2009-10-21Clinical Trial Update: TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating TP-38 toxin in pediatric patients with recurrent or progressive supratentorial high-grade glioma…
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM [Phase 2]
Phase 2 trial evaluating Gliadel Wafer with Temozolomide and radiation for newly diagnosed glioblastoma multiforme/high-grade glioma has bee…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-02Clinical Trial Update: Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 [EARLY_Phase 1]
Siemens Molecular Imaging completed an exploratory Phase 0 PET imaging study of the F-18 RGD-K5 tracer. The study evaluated imaging across m…
-
CLINICAL_TRIALS trial_result · 2007-11-21Clinical Trial Update: Nimotuzumab in Children With HGG
A completed clinical trial investigating Nimotuzumab in children with high-grade glioma; the update notes trial status without detailing res…